ODDB.org: Open Drug Database | Drugs

Mepha Pharma AG - Buprenorphin-Mepha 70 ug/h, Transdermale Pflaster

Swissmedic Registration	65809	Sequence	03
Product name	Buprenorphin-Mepha 70 ug/h	Description	Transdermale Pflaster
ATC-Classification	N02AE01	ATC-Description	Buprenorphine
Introduction of Sequence	19.05.2015

Composition

buprenorphinum 40 mg, oleylis oleas, povidonum K 90, acidum laevulinicum, acrylates et vinylis acetatis polymerisatum (vernetzt), poly(ethylenis terephthalas), acrylates et vinylis acetatis polymerisatum (nicht vernetzt), Trägermaterial: poly(ethylenis terephthalas), ad praeparationem pro 50 cm², cum liberatione 70 µg/h.

Packungsbestandteile

Galenic Form

Transdermale Pflaster

Excipiens

Active Agent	Dose
Buprenorphine	40 mg

BAG: Active Agent	Dose
Buprenorphine	40 mg

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
011	4	50.70	71.55	A+	SL	Yes
012	8	96.44	121.30	A+	SL	Yes

2025	©ywesee GmbH